⁵¹Cr-Ethylenediaminetetraacetic Acid Absorption Test: Methodologic Aspects

References

• Menzies I S, Pounder R, Heyer S, Laker M F, Bull J, Wheeler P G, Creamer B. Abnormal intestinal permeability to sugars in villous atrophy. Lancet 1979; 2: 1107–1109
   PubMed Web of Science ®Google Scholar
• Chadwick V S, Phillips S F, Hofmann A F. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). Gastroenterology 1977; 72: 247–251
   Google Scholar
• Peters T J, Bjarnason I. Intestinal permeability. Food and the gut, J O Hunter, V Jones Akin. Bailliere Tindall Ltd, London 1985; 30–43
   Google Scholar
• Bjarnason I, Peters T J. A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test. Lancet 1983; 1: 323–325
   PubMed Web of Science ®Google Scholar
• Bjarnason I, O'Morain C, Levi A J, Peters T J. Absorption of 51-chromium-labeled ethylene-dia-mine-tetraacetate in inflammatory bowel disease. Gastroenterology 1983; 85: 318–322
   PubMed Web of Science ®Google Scholar
• Forget P, Sodoyez-Goffaux F, Zapitelli A. Permeability of the small intestine to 51Cr-EDTA in children with acute gastroenteritis or eczema. J Pediatr Gastroenterol Nutr 1985; 4: 393–396
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Marsh M N, Price A, Levi N, Peters T J. Intestinal permeability in patients with coeliac disease and dermatitis herpetiformis. Gut 1985; 26(11)1214–1219
   PubMed Web of Science ®Google Scholar
• Leclercq-Foucart J, Forget P, Sodoyez-Goffaw F, Zappitelti A. Intestinal permeability to (51Cr)EDTA in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 1986; 5: 384–387
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Ward K, Peters T J. The leaky gut of alcoholism. Possible route of entry for toxic compounds. Lancet 1984; 1: 179–182
   PubMed Web of Science ®Google Scholar
• Bjarnason I, So A, Levi A J, Peters T J, Williams P, Zanelli G D, Gumpel J M, et al. Intestinal permeability and inflammation in rheumatoid arthritis: Effects of non-steroidal anti-inflammatory drugs. Lancet 1984; 2: 1171–1174
   PubMed Web of Science ®Google Scholar
• Levitt M D, Donaldson R M. Use of respiratory hydrogen (H2) excretion to detect carbohydrate malabsorption. J Lab Clin Med 1970; 75: 937–945
   PubMed Web of Science ®Google Scholar
• Lehmann E L, D'Abrerd H JM. Nonparametrics: statistical method based on ranks. Holden-Day Inc., San Francisco 1975
   Google Scholar
• Sandvik L, Olsson B. A nearly distribution-free test for comparing dispersion in paired samples. Biometrika 1982; 69: 484–485
   Web of Science ®Google Scholar
• Kendall M. Rank correlation methods. Charles Griffin & Co. Ltd., London 1975
   Google Scholar
• Løkken P. Studies on ⁵¹Cr-EDTA and its evaluation as a reference substance in gastro-intestinal research. Universitetsforlaget, Oslo 1970
   Google Scholar
• Jones J G, Lawley P, Crawley J CW, Minty B D, Hulands G, Veall N. Increased alveolar epithelial permeability in cigarette smokers. Lancet 1980; 1: 6647
   Web of Science ®Google Scholar
• Trap-Jensen J. Increased capillary permeability to 131iodide and 51Cr-EDTA in the exercising forearm of long term diabetics. Clin Sci 1970; 39: 39–49
   PubMed Web of Science ®Google Scholar
• Chantler C, Garnett E S, Parsons V, Veall N. Glom-erular filtration rate measurement in man by the single injection method using 51Cr EDTA. Clin Sci 1969; 37: 169–180
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Peters T J, Levi A J. Intestinal permeability: clinical correlates. J Dig Dis 1986; 4: 83–92
   Google Scholar
• Bjarnason I, Williams P, Smethurst P, Peters T J, Levi A J. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut 1986; 27: 1292–1297
   PubMed Web of Science ®Google Scholar
• Auer I O, Habscheid W, Hiller S, Gerhards W, Eilles C. Nicht-steroidal Antiphlogistika erhöhen die Darmpermeabilität. Dtsch Med Wochenschr 1987; 112: 1032–1037
   PubMedGoogle Scholar
• Lange J, Bjarnason I, Levi A J, Price A. Pathology of iatrogenic ileal strictures due to NSAIDs. Gut 1985; 26: A542
   Google Scholar
• Langman M JS, Morgan L, Worrall A. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br Med J 1985; 290: 347–349
   PubMed Web of Science ®Google Scholar
• Madhok R, Mackenzie A, Lee F D. Small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs for rheumatoid arthritis. Q J Med 1986; 255: 53–58
   Google Scholar
• Shack M E. Drug induced ulceration and perforation of the small intestine. Ariz Med 1966; 23: 517–523
   PubMedGoogle Scholar
• Lanza F L. Endoscopic studies of gastric and duodenal injury after the use of Ibuprofen, Aspirin, and other non-steroid antiinflammatory agents. Am J Med 1984; 77: 19–24
   PubMed Web of Science ®Google Scholar
• Simpson L O. NSAID and the leaky gut (letter). Lancet 1985; I: 218–219
   Google Scholar
• Peled Y, Watz C, Gilat T. Measurement of intestinal permeability using 51Cr-EDTA. Am J Gastroenterol 1985; 80: 770–773
   PubMed Web of Science ®Google Scholar
• Jenkins R T, Lock C JL, Rooney P J. 51Cr-EDTA in studies of intestinal permeability (letter). Lancet 1984; 2: 1342
   PubMed Web of Science ®Google Scholar
• Cobden I, Rothwell J, Axon A TR. Intestinal permeability in coeliac disease. Lancet 1983; 1: 829
   PubMedGoogle Scholar
• O'Mahony C P, Stevens F M, Bourke M. 51Cr-EDTA test for coeliac disease. Lancet 1984; 1: 354–355
   Google Scholar
• Benoni C, Prytz H, Tagesson C. Does smoking tighten the gut? (abstract). Scand J Gastroenterol 1988; 23(suppl 145)42
   PubMed Web of Science ®Google Scholar
• Veall N. Intestinal permeability (letter). Lancet 1985; 1: 588
   PubMedGoogle Scholar
• Elia M, Behrens R, Northrop C, Wraight P, Neale G. Evaluation of mannitol, lactulose and 51Cr-labelled ethylene-diaminetetra-acetate as markers of intestinal permeability in man. Clin Sci 1987; 73: 197–204
   Web of Science ®Google Scholar
• Jenkins R T, Jones D B, Goodacre R L, Collins S M, Coates G, Hunt R H, Bienenstock J. Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases. Am J Gastroenterol 1987; 82: 1159–1164
   PubMed Web of Science ®Google Scholar
• Maxton D G, Bjarnason I, Reynolds A P, Catt S D, Peters T J, Menzies I S. Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 500 as probe markers for assessment in vivo of human intestinal permeability. Clin Sci 1986; 71: 71–80
   PubMed Web of Science ®Google Scholar
• Cooper B T. Small intestinal permeability in clinical practice. J Clin Gastroenterol 1984; 6: 499–501
   PubMed Web of Science ®Google Scholar
• Ukabam S O, Cooper B T. Small intestinal permeability to mannitol, lactulose and PEG 400 in celiac disease. Dig Dis Sci 1984; 29: 809–816
   PubMed Web of Science ®Google Scholar